Company / Current Liabilities
Royalty Pharma plc Current Liabilities History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$636.2M
FY2025
5-year range
$161.4M / $1.3B
FY2021-FY2025
Trend
-49.2%
vs FY2024
Sector context
#32 of 213
Health Care
What the data says
Royalty Pharma plc's current liabilities of $636M is higher than 85% of companies in the Health Care sector (FY2025). Current Liabilities has fluctuated over the past 7 years, ranging from $161M in FY2023 to $1.3B in FY2024.
Based on SEC 10-K filings.
$636M in FY2025 with a 5-year CAGR of +15.6%. Top quartile in the Health Care sector.
Increased from $161M to $636M over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- -18.3%
- 5-Year CAGR
- +15.6%
- 10-Year CAGR
- -
Sector benchmark
-59.9% below sector average
Key checks
Key Insights
- 5-year CAGR of +15.6%, indicating consistent growth.
- In FY2025, current liabilities decreased 49.2% year-over-year.
- Ranks #32 out of 213 companies in the Health Care sector.
- Peak current liabilities was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 0.91 (distress zone, below 1.8 threshold)
- Strong profit margin: 38.0%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $636.2M | -49.2% |
| FY2024 | $1.3B | +676.8% |
| FY2023 | $161.4M | -86.2% |
| FY2022 | $1.2B | +581.3% |
| FY2021 | $171.3M | -44.4% |
| FY2020 | $307.9M | -7.7% |
| FY2019 | $333.4M | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026